A translational perspective on epigenetics in allergic diseases

Area of Science:

• Allergy and Immunology
• Epigenetics
• Environmental Health

Background:

• Epigenetic modifications are increasingly recognized for their role in mediating environmental influences on allergic disease development.
• Altered epigenomic landscapes have been observed in cells relevant to allergic conditions.
• Epigenetics offers potential insights into disease mechanisms and personalized medicine.

Purpose of the Study:

• To explore the role of epigenetic modifications in allergic diseases.
• To evaluate the potential of epigenetic markers for patient stratification and treatment monitoring.
• To discuss novel therapeutic strategies targeting the epigenome and microbiome interactions.

Main Methods:

• Analysis of epigenetic modifications, focusing on DNA methylation and microRNAs.
• Review of current research on epigenomic landscapes in disease-relevant cell populations.
• Examination of emerging therapeutic interventions and their clinical trial status.

Main Results:

• Epigenetic modifications, particularly DNA methylation and microRNAs, show potential as biomarkers for patient stratification and predicting immunotherapy outcomes.
• Early evidence suggests epigenetic markers can complement or replace traditional diagnostic tests.
• Novel therapeutic approaches involving microRNA modulation and epigenetic editing are under investigation.

Conclusions:

• Epigenetic modifications are crucial in allergic diseases, offering potential for personalized treatment and monitoring.
• Further research in larger cohorts is necessary to validate epigenetic biomarkers for clinical implementation.
• Targeting the epigenome and its interaction with the microbiome presents promising avenues for allergy prevention and treatment.